Literature DB >> 20670510

Superselective Intra-arterial Thrombolysis for Acute Cardioembolic Stroke in a Child with Idiopathic Dilated Cardiomyopathy. A Case Report.

E Kitzmüller1, A Gruber, M Marx, M Schlemmer, M Wimmer, B Richling.   

Abstract

SUMMARY: We describe a case of cardioembolic dominant hemisphere internal carotid artery occlusion in a child with idiopathic dilated cardiomyopathy. The patient was subjected to superselective local intra-arterial thrombolysis using recombinant tissue plasminogen activator (A lteplase; Actilyse((R))). In presence of good collateral flow local intra-arterial thrombolysis prevented a major dominant hemisphere ischaemic stroke, although post-interventional computed tomographic scans disclosed haemorrhagic conversion in the left corpus striatum. Forty eight months after ischaemic stroke and thrombolysis the patient is ambulatory with a moderate neurologic deficit.

Entities:  

Year:  2001        PMID: 20670510      PMCID: PMC4268686          DOI: 10.1177/159101999900500213

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  45 in total

1.  Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset.

Authors:  E C Haley; D E Levy; T G Brott; G L Sheppard; M C Wong; G L Kongable; J C Torner; J R Marler
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

2.  Local intra-arterial fibrinolysis in thromboembolic "T" occlusions of the internal carotid artery.

Authors:  H Urbach; F Ries; B Ostertun; L Solymosi
Journal:  Neuroradiology       Date:  1997-02       Impact factor: 2.804

3.  Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061).

Authors:  T Hara; M Iwamoto; H Ogawa; A Yamamoto; M Tomikawa
Journal:  Thromb Res       Date:  1990-08-15       Impact factor: 3.944

4.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

5.  Dilated cardiomyopathy and thrombo-embolism.

Authors:  J Günthard; F Stocker; D Bolz; E Jäggi; R Ghisla; I Oberhänsli; F Wyler
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Intra-arterial thrombolysis in acute ischaemic stroke: experience with a superselective catheter embedded in the clot.

Authors:  L Casto; L Caverni; M Camerlingo; B Censori; L Moschini; M C Servalli; T Partziguian; G Belloni; A Mamoli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

8.  Outcome of infants and children with dilated cardiomyopathy.

Authors:  A B Lewis; M Chabot
Journal:  Am J Cardiol       Date:  1991-08-01       Impact factor: 2.778

Review 9.  Thrombolysis in ischaemic stroke--how far from a clinical breakthrough?

Authors:  G Boysen; K Overgaard
Journal:  J Intern Med       Date:  1995-01       Impact factor: 8.989

10.  Prognostic features of children with idiopathic dilated cardiomyopathy.

Authors:  H B Wiles; P D McArthur; A B Taylor; P C Gillette; D A Fyfe; J P Matthews; L W Shelton
Journal:  Am J Cardiol       Date:  1991-11-15       Impact factor: 2.778

View more
  1 in total

Review 1.  Antithrombotic drug treatment of pediatric patients with ischemic stroke.

Authors:  Ulrike Nowak-Göttl; Ronald Sträeter; Guillaume Sébire; Fenella Kirkham
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.